Tempus AI, Inc. TEM is scheduled to report first-quarter fiscal 2025 results on May 6. In the last reported quarter, the company’s adjusted loss of 18 cents was wider than the Zacks Consensus Estimate ...

Molecular testing is transforming post-transplant care, reducing the need for invasive biopsies and personalizing medication ...